Thrombosis after the use of a heparin-coated cardiopulmonary bypass circuit in a patient with heparin-induced thrombocytopenia

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 10, Issue 6, 1996, Pages 809-815

  Van Dyck, M J ^a   Lavenne Pardonge, E ^a   Azerad, M A ^a   Matta, A G ^a   Moriau, M ^a   Comunale, M E ^a   Schwartz, A J ^a   Hensley F A , Jr ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

cardiac surgery; cardiopulmonary bypass; heparin; thrombocytopenia

Indexed keywords

HEPARIN; ILOPROST; LOW MOLECULAR WEIGHT HEPARIN; MIDAZOLAM; PROTAMINE; SUFENTANIL; WARFARIN; ANTICOAGULANT AGENT;

ADULT; BLEEDING; CARDIOPULMONARY BYPASS; CASE REPORT; CONFERENCE PAPER; CORONARY ARTERY OBSTRUCTION; DRUG INDUCED DISEASE; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HEPARINIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; MIDDLE AGED;

ANTICOAGULANTS; CARDIOPULMONARY BYPASS; FEMALE; HEPARIN; HUMANS; MIDDLE AGED; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0030254320     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(96)80211-4     Document Type: Conference Paper

References (47)

1. (editorial) Aster RH Heparin-induced thrombocytopenia and thrombosis N Engl J Med 332 1995 1374 1376
2. Kelton JG Smith JW Warkentin TE Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4 Blood 83 1994 3232 3239
3. Greinacher A Pötzsch B Amiral J Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen Thromb Haemost 71 1994 247 251
4. Amiral J Bridey F Wolf M Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: A study of 44 cases Thromb Haemost 73 1995 21 28
5. Gravlee GP Anticoagulation for cardiopulmonary bypass Gravlee GP Davis RF Utley JR Cardiopulmonary Bypass, Principles, and Practice 1993 Williams & Wilkins Baltimore 364 369
6. Singer RL Mannion JD Bauer TL Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass Chest 104 1993 1436 1440
7. Palmer Smith J Walls JT Muscato MS Extracorporeal circulation in a patient with heparin-induced thrombocytopenia Anesthesiology 62 1985 363 365
8. Munver R Schulman IC Wolf DJ Heparin-induced thrombocytopenia and thrombosis: presentation after cardiopulmonary bypass Ann Thorac Surg 58 1994 1764 1766
9. Kalangos A Relland JY Massonet-Castel S Heparininduced thrombocytopenia and thrombosis following open heart surgery Eur J Cardiothorac Surg 8 1994 199 203
10. Kraenzler EJ Starr NJ Heparin-associated thrombocytopenia: Management of patients for open heart surgery. Case reports describing the use of iloprost Anesthesiology 69 1988 964 967
11. Corbeau JJ Jacob JP Moreau X Iloprost (Ilomedine) et circulation extracorporelle avec héparinisation conventionnelle chez un patient ayant une thrombocytopénie à l'héparine Ann Fr Anesth Réanim 12 1993 55 59
12. Shorten G Comunale ME Johnson RG Management of cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia using prostaglandin E1 and aspirin J Cardiothorac Vasc Anesth 8 1994 556 558
13. Brady J Riccio JA Yumen OH Plasmapheresis: A therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis Am J Clin Pathol 96 1991 394 397
14. O Yurvati AH Laub GW Southgate TJ Heparinless cardiopulmonary bypass with ancrod Ann Thorac Surg 57 1994 1656 1658
15. Spiekermann BF Lake CL Rich GF Normal activated clotting time despite adequate anticoagulation with ancrod in a patient with heparin-associated thrombocytopenia and thrombosis undergoing cardiopulmonary bypass Anesthesiology 80 1994 686 688
16. Riess FC Löwer C Seelig C Recombinant hirudin as a new anticoagulant during cardiac operations instead of heparin: Successful for aortic valve replacement in man J Thorac Cardiovasc Surg 110 1995 265 267
17. Chong BH Mangnani HN Orgaran in heparin-induced thrombocytopenia Haemostasis 22 1992 85 91
18. Robitaille D Leclerc JR Laberge R Cardiopulmonary bypass with a low-molecular-weight heparin fraction (enoxaparin) in a patient with a history of heparin-associated thrombocytopenia J Thorac Cardiovasc Surg 103 1992 597 599
19. Altés A Martino R Gari M Heparin-induced thrombocytopenia and heart operation: Management with tedelparin Ann Thorac Surg 59 1995 509 511
20. Videm V Mollnes TE Garred P Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits J Thorac Cardiovasc Surg 101 1991 654 660
21. Fosse E Moen O Johnson E Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass Ann Thorac Surg 58 1994 472 477
22. Svennevig JL Geiran OR Karlsen H Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits J Thorac Cardiovasc Surg 106 1993 466 472
23. Boshkov LK Warkentin TE Hayward CP Heparininduced thrombocytopenia and thrombosis: Clinical and laboratory studies Br J Haematol 84 1993 322 328
24. Kelton JG Sheridan D Brain H Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia J Lab Clin Med 103 1984 606 612
25. Sheridan D Carter C Kelton JG A diagnostic test for heparin-induced thrombocytopenia Blood 67 1986 27 30
26. Moberg PQ Geary VM Sheikh FM Heparin-induced thrombocytopenia: A possible complication of heparin-coated pulmonary artery catheters J Cardiothorac Anesth 4 1990 226 228
27. Laster J Silver D Heparin-coated catheters and heparin-induced thrombocytopenia J Vasc Surg 7 1988 667 672
28. Couyant MA Beemer GH Tatoulis J A proposed protocol for the management of cardiopulmonary bypass for patients with heparin-induced thrombocytopenia syndrome Austras Perfusion Soc J 1 1992 33 36
29. von Segesser LK Weiss BM Pasic M Risk and benefit of low systemic heparinization during open heart operations Ann Thorac Surg 58 1994 391 398
30. Walenga JM Bakhos M Messmore HL Potential use of recombinant Hirudin as anticoagulation in a cardiopulmonary bypass model Ann Thorac Surg 51 1991 271 277
31. Nand S Hirudin therapy for heparin-associated thrombocytopenia and deep venous thrombosis Am J Hematol 43 1993 310 311
32. (editorial) Edmunds LH Jr HIT, HITT, and desulfatohirudin: Look before you leap J Thorac Cardiovasc Surg 110 1995 1 3
33. Brister SJ Buchanan MR Heparinless cardiopulmonary bypass revisited: A newer strategy to avoid heparin-related bleeding using dermatan sulfate J Cardiothorac Vasc Anesth 9 1995 317 321
34. (letter) Gouault-Heilmann M Huet Y Contant G Cardiopulmonary bypass with a low-molecular-weight heparin fraction Lancet II 1983 1374
35. (letter) Massonnet-Castel S Pelissier E Dreyfus G Low-molecular-weight heparin in extracorporeal circulation Lancet I 1984 1182 1183
36. (letter) Roussi JH Houbouyan LL Goguel AF Use of low-molecular-weight heparin in heparin-induced thrombocytopenia with thrombotic complications Lancet I 1984 1183
37. Dreyfus G Massonnet-Castel S Pélissier E Etude d'une héparine de bas poids moléculaire au cours des circulations extracorporelles. Premières applications cliniques Arch Mal Coeur 13 1986 1851 1857
38. Drakos P Uziely B Nagler A Successful administration of low molecular weight heparin in a patient with heparin-induced thrombocytopenia and coumarin-induced skin necrosis Haemostasis 23 1993 259 262
39. Warkentin TE Levine MN Hirsh J Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330 1335
40. Frame JN Mulvey KP Phares JC Correction of severe heparin-associated thrombocytopenia with intravenous immunoglobulin Ann Intern Med 111 1989 946 947
41. Kappa JR Fisher CA Berkowitz HD Heparin-induced platelet activation in sixteen surgical patients: Diagnosis and management J Vasc Surg 5 1987 101 109
42. Kapsch DN Adelstein EH Rhodes GR Heparin-induced thrombocytopenia thrombosis, and hemorrhage Surgery 86 1979 148 155
43. Olinger GN Hussey CV Olive JA Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation J Thorac Cardiovasc Surg 87 1984 673 677
44. Thelin S Bagge L Hultman J Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig Eur J Cardiothorac Surg 5 1991 486 491
45. Hsu L-C Heparin coating of bypass circuits. Principles of heparin-coating techniques Perfusion 6 1991 209 219
46. Gorman RR Bunting S Miller OV Modulation of human platelet adenylate cyclase by prostacyclin (PGX) Prostaglandins 13 1977 377 388
47. Schwarz RP, Becker JC, Brooks RL, et al: The preclinical and clinical pharmacology of NOVASTAN (Argatroban): A small-molecule, direct thrombin inhibitor. J Clin Appl Thromb Hemo (accepted for publication)